Orascom-Siemens-Arab Contractors consortium signs MoU to build high-speed rail system    Oman to close land borders again to curb coronavirus    State revenues will likely fall by EGP 150 bln in FY 2020/21 on Covid-19    Transmar succeeded in promoting trade, doubling reefer container shipping    Gut bacteria tied to Covid-19 severity    Egypt receives 19 rail carriages from Russia under mega deal    New boss Rooney backs Derby to respond after defeat by Rotherham    CBE offers EGP 16bn T-bills on Sunday    World Bank provides $200m loan to Egypt for air quality monitoring projects    Egypt detects 887 new coronavirus cases; 54 fatalities on Saturday    Live score: National Bank of Egypt v Ahly (Egyptian Premier League)    Facebook to ban ads promoting weapon accessories, protective gear in US    Explainer: Road to Palestinian vote full of obstacles    Tennis: Australian Open arrivals hit by 4 COVID-19 positive tests    US state capitals, Washington on alert for possible pro-Trump armed protests    In Photos: Egyptian archaeological mission at Saqqara Necropolis announces new major discoveries    Armin Laschet picked as new leader of Germany's CDU party    Egypt's Sisi discusses bilateral ties, regional developments with Sudanese delegation    Bank ABC acquires Blom Bank Egypt for $480 million: Sources    Egypt's Mostaqbal Watan party dominates the leading posts of parliament's 25 committees    Egypt's budget deficit to GDP ratio receded to 3.6% in first half of FY2020/21, revenues rose by 16%    Mubarak-era politician Safwat El-Sherif dies aged 88    Handball: Egypt ease past Chile 35-29 in World Championship opener    Egypt's president, Siemens CEO discuss final deal on construction of electric train system    Hollywood actor Mena Massoud visits Giza pyramids, says is proud of Egyptian culture    Egypt reopens airspace and resumes flights with Qatar    Egypt, Tunisia to establish maritime trade route    Egypt eyes gradual return for tourism after revenues fall to $4 bln in 2020    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Coronavirus strikes Egypt's youth team as 17 players, coach test positive    Nassef Sawiris plans to up his stake in owner of New York Knicks, Rangers    Cairo International Book Fair suspended for five months over coronavirus concerns    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

FACTBOX: China's coronavirus vaccine development efforts
Published in Ahram Online on 24 - 08 - 2020

China has several novel coronavirus vaccine candidates in the late stage of development.
Below is a summary of its efforts to develop vaccines.
Four of the world's seven vaccines that are in the third phase of trials are from China.
Two of the candidates are from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm).
Sinovac Biotech is developing the third candidate called CoronaVac, while CanSino Biologics is working with state military research unit Academy of Military Medical Sciences on Ad5-nCoV.
Argentina, Peru, Morocco, Bahrain and the United Arab Emirates have allowed CNBG to run Phase 3 trials. It's not immediately clear if the company's two vaccine candidates will be tested in those countries.
Indonesia and Brazil are helping with Phase 3 trials of Sinovac's CoronaVac, while Bangladesh aims to run a late stage clinical trial for the experimental vaccine.
Pakistan, Saudi Arabia and Russia have agreed to conduct Phase 3 trials of CanSino's candidate, while Mexico has signed an early agreement with the Chinese firm for a late-stage trial.
China has been administering experimental coronavirus vaccines to groups facing high infection risks such as medical workers since July under an "emergency use" programme.
Authorities could consider modestly expanding the emergency use programme to try to prevent outbreaks during the autumn and winter.
China has not specified how many people have been vaccinated or which product has been given.
Before the official launch of the programme in July, China's military approved the use of CanSino's vaccine, in June, while state media reported in June that employees at state-owned firms travelling overseas were allowed to take one of the two candidate vaccines being developed by CNBG.

Clic here to read the story from its source.